357 related articles for article (PubMed ID: 26264222)
41. The critical role of dysregulated FOXM1-PLAUR signaling in human colon cancer progression and metastasis.
Li D; Wei P; Peng Z; Huang C; Tang H; Jia Z; Cui J; Le X; Huang S; Xie K
Clin Cancer Res; 2013 Jan; 19(1):62-72. PubMed ID: 23136192
[TBL] [Abstract][Full Text] [Related]
42. MicroRNA-155 and FOXP3 jointly inhibit the migration and invasion of colorectal cancer cells by regulating ZEB2 expression.
Yang LP; Lin Q; Mu XL
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6131-6138. PubMed ID: 31364113
[TBL] [Abstract][Full Text] [Related]
43. FoxM1 influences mouse hepatocellular carcinoma metastasis in vitro.
Zhang N; Xie Y; Li B; Ning Z; Wang A; Cui X
Int J Clin Exp Pathol; 2015; 8(3):2771-8. PubMed ID: 26045783
[TBL] [Abstract][Full Text] [Related]
44. Sequential Treatment with Activin and Hepatocyte Growth Factor Induces FOXM1 to Promote Colorectal Cancer Liver Metastasis.
Peng H; Ye T; Deng L; Yang X; Jiang Z; Guo J
Can J Gastroenterol Hepatol; 2022; 2022():8996203. PubMed ID: 36591565
[TBL] [Abstract][Full Text] [Related]
45. Role of MCP-1 in alcohol-induced aggressiveness of colorectal cancer cells.
Xu M; Wang S; Qi Y; Chen L; Frank JA; Yang XH; Zhang Z; Shi X; Luo J
Mol Carcinog; 2016 May; 55(5):1002-11. PubMed ID: 26014148
[TBL] [Abstract][Full Text] [Related]
46. IWR-1 inhibits epithelial-mesenchymal transition of colorectal cancer cells through suppressing Wnt/β-catenin signaling as well as survivin expression.
Lee SC; Kim OH; Lee SK; Kim SJ
Oncotarget; 2015 Sep; 6(29):27146-59. PubMed ID: 26450645
[TBL] [Abstract][Full Text] [Related]
47. Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer.
Lian J; Tang J; Shi H; Li H; Zhen T; Xie W; Zhang F; Yang Y; Han A
Oncotarget; 2015 Oct; 6(30):29357-74. PubMed ID: 26296979
[TBL] [Abstract][Full Text] [Related]
48. FOXM1c promotes pancreatic cancer epithelial-to-mesenchymal transition and metastasis via upregulation of expression of the urokinase plasminogen activator system.
Huang C; Xie D; Cui J; Li Q; Gao Y; Xie K
Clin Cancer Res; 2014 Mar; 20(6):1477-88. PubMed ID: 24452790
[TBL] [Abstract][Full Text] [Related]
49. PARI functions as a new transcriptional target of FOXM1 involved in gastric cancer development.
Zhang Y; Ye X; Chen L; Wu Q; Gao Y; Li Y
Int J Biol Sci; 2018; 14(5):531-541. PubMed ID: 29805304
[TBL] [Abstract][Full Text] [Related]
50. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
[TBL] [Abstract][Full Text] [Related]
51. Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression.
Kwok JM; Myatt SS; Marson CM; Coombes RC; Constantinidou D; Lam EW
Mol Cancer Ther; 2008 Jul; 7(7):2022-32. PubMed ID: 18645012
[TBL] [Abstract][Full Text] [Related]
52. FOXM1-LDHA signaling promoted gastric cancer glycolytic phenotype and progression.
Jiang W; Zhou F; Li N; Li Q; Wang L
Int J Clin Exp Pathol; 2015; 8(6):6756-63. PubMed ID: 26261559
[TBL] [Abstract][Full Text] [Related]
53. A Positive Feedback Loop of lncRNA-
Xu MD; Wang Y; Weng W; Wei P; Qi P; Zhang Q; Tan C; Ni SJ; Dong L; Yang Y; Lin W; Xu Q; Huang D; Huang Z; Ma Y; Zhang W; Sheng W; Du X
Clin Cancer Res; 2017 Apr; 23(8):2071-2080. PubMed ID: 27756785
[No Abstract] [Full Text] [Related]
54. FoxM1 promotes breast tumorigenesis by activating PDGF-A and forming a positive feedback loop with the PDGF/AKT signaling pathway.
Yu G; Zhou A; Xue J; Huang C; Zhang X; Kang SH; Chiu WT; Tan C; Xie K; Wang J; Huang S
Oncotarget; 2015 May; 6(13):11281-94. PubMed ID: 25869208
[TBL] [Abstract][Full Text] [Related]
55. Sorafenib inhibits proliferation and invasion of human hepatocellular carcinoma cells via up-regulation of p53 and suppressing FoxM1.
Wei JC; Meng FD; Qu K; Wang ZX; Wu QF; Zhang LQ; Pang Q; Liu C
Acta Pharmacol Sin; 2015 Feb; 36(2):241-51. PubMed ID: 25557114
[TBL] [Abstract][Full Text] [Related]
56. MicroRNA-215-3p Suppresses the Growth, Migration, and Invasion of Colorectal Cancer by Targeting FOXM1.
Tang X; Shi X; Wang N; Peng W; Cheng Z
Technol Cancer Res Treat; 2019; 18():1533033819874776. PubMed ID: 31607224
[TBL] [Abstract][Full Text] [Related]
57. LPS Upregulated VEGFR-3 Expression Promote Migration and Invasion in Colorectal Cancer via a Mechanism of Increased NF-κB Binding to the Promoter of VEGFR-3.
Zhu G; Huang Q; Zheng W; Huang Y; Hua J; Yang S; Zhuang J; Wang J; Chang J; Xu J; Ye J
Cell Physiol Biochem; 2016; 39(5):1665-1678. PubMed ID: 27639612
[TBL] [Abstract][Full Text] [Related]
58. FOXM1 is a downstream target of LPA and YAP oncogenic signaling pathways in high grade serous ovarian cancer.
Fan Q; Cai Q; Xu Y
Oncotarget; 2015 Sep; 6(29):27688-99. PubMed ID: 26299613
[TBL] [Abstract][Full Text] [Related]
59. FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function.
Song IS; Jeong YJ; Jeong SH; Heo HJ; Kim HK; Bae KB; Park YH; Kim SU; Kim JM; Kim N; Ko KS; Rhee BD; Han J
Gastroenterology; 2015 Oct; 149(4):1006-16.e9. PubMed ID: 26091938
[TBL] [Abstract][Full Text] [Related]
60. The FOXM1-induced resistance to oxaliplatin is partially mediated by its novel target gene Mcl-1 in gastric cancer cells.
Hu CJ; Wang B; Tang B; Chen BJ; Xiao YF; Qin Y; Yong X; Luo G; Zhang JW; Zhang D; Li S; He F; Yang SM
Biochim Biophys Acta; 2015 Mar; 1849(3):290-9. PubMed ID: 25482013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
